Curebase has announced the release of its integrated software and services package for digital therapeutics (DTx) trials. Available now, the new offering includes a DCT platform bundled with site and trial execution services for the DTx market.
This blend of eClinical software and technology-driven services enables sponsors of DTx studies to leverage the following Curebase capabilities:
Read more about the new offering here.
FDA issues de novo clearance for SonoMotion’s Stone Clear device, for kidney stone treatment
Stone Clear is the first and only device cleared by the FDA that uses external ultrasound pulses to facilitate passage of post-lithotripsy kidney stone fragments without surgery.